Prescription RequiredMOUNJARO KwikPen (Tirzepatide) 15 mg/0.6 mL is a prescription once-weekly injectable medicine used to improve blood sugar control in adults with type 2 diabetes. It contains tirzepatide, a dual GIP and GLP-1 receptor agonist that helps regulate blood glucose levels, support weight management, and reduce appetite when combined with a healthy diet and regular physical activity.
| Generic name | Tirzepatide |
| Strength | 15 mg |
| Manufacturer | Eli Lilly and Company |
| Package size | 1 pre-filled 2.4 ml pen |
| Used for | Type 2 diabetes and chronic weight management |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, UAE, Georgia, Armenia, Saudi Arabia, Qatar, Kuwait, South Africa, and many other countries. |
Tirzepatide 15 mg works by activating both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors. It stimulates insulin release when blood sugar levels are elevated, decreases glucagon production, slows stomach emptying, and helps reduce appetite. These combined effects improve blood sugar control and support weight management.
Dr. Unnati Mehra has professional experience supporting patients with diabetes and related metabolic conditions. She follows an individualised approach to blood glucose management that considers prescribed medicines, glucose readings, nutrition, physical activity and overall health.
